Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 8.39386544 |
2 | central nervous system myelination (GO:0022010) | 8.39386544 |
3 | hemidesmosome assembly (GO:0031581) | 7.03912354 |
4 | desmosome organization (GO:0002934) | 6.36433243 |
5 | fatty acid elongation (GO:0030497) | 5.62397967 |
6 | * ensheathment of neurons (GO:0007272) | 5.32573083 |
7 | * axon ensheathment (GO:0008366) | 5.32573083 |
8 | * myelination (GO:0042552) | 5.26473296 |
9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.92367827 |
10 | COPI coating of Golgi vesicle (GO:0048205) | 4.85097722 |
11 | Golgi transport vesicle coating (GO:0048200) | 4.85097722 |
12 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.59580887 |
13 | L-amino acid import (GO:0043092) | 4.56429632 |
14 | cell adhesion mediated by integrin (GO:0033627) | 4.55989455 |
15 | myelin maintenance (GO:0043217) | 4.53564038 |
16 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.42686230 |
17 | skin morphogenesis (GO:0043589) | 4.33508432 |
18 | response to methylmercury (GO:0051597) | 4.23152385 |
19 | negative regulation of neurotransmitter transport (GO:0051589) | 4.21831420 |
20 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.11792656 |
21 | protein retention in ER lumen (GO:0006621) | 4.11509057 |
22 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.94387877 |
23 | regulation of collateral sprouting (GO:0048670) | 3.81900373 |
24 | cell-substrate junction assembly (GO:0007044) | 3.67823890 |
25 | establishment of mitochondrion localization (GO:0051654) | 3.66787913 |
26 | neuron cell-cell adhesion (GO:0007158) | 3.64815383 |
27 | cholesterol biosynthetic process (GO:0006695) | 3.63617917 |
28 | presynaptic membrane organization (GO:0097090) | 3.57229252 |
29 | amino acid import (GO:0043090) | 3.51682305 |
30 | presynaptic membrane assembly (GO:0097105) | 3.51119824 |
31 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.50940465 |
32 | cellular copper ion homeostasis (GO:0006878) | 3.48790319 |
33 | epithelial cell-cell adhesion (GO:0090136) | 3.48583733 |
34 | negative regulation of protein localization to cell surface (GO:2000009) | 3.46341246 |
35 | mesodermal cell differentiation (GO:0048333) | 3.44062017 |
36 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.38398780 |
37 | oligodendrocyte differentiation (GO:0048709) | 3.36638644 |
38 | glycerophospholipid catabolic process (GO:0046475) | 3.31341186 |
39 | creatine metabolic process (GO:0006600) | 3.24746032 |
40 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.22833073 |
41 | serine transport (GO:0032329) | 3.21854355 |
42 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.20976611 |
43 | sterol biosynthetic process (GO:0016126) | 3.20935708 |
44 | neuron remodeling (GO:0016322) | 3.20815819 |
45 | isoprenoid biosynthetic process (GO:0008299) | 3.16202760 |
46 | regulation of cholesterol homeostasis (GO:2000188) | 3.12678585 |
47 | neuronal action potential propagation (GO:0019227) | 3.11627333 |
48 | keratinocyte proliferation (GO:0043616) | 3.09823008 |
49 | substantia nigra development (GO:0021762) | 3.09173117 |
50 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.09051548 |
51 | semaphorin-plexin signaling pathway (GO:0071526) | 3.07982003 |
52 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.07964142 |
53 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.07342426 |
54 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.07265296 |
55 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.07265296 |
56 | amyloid precursor protein metabolic process (GO:0042982) | 3.05853315 |
57 | asymmetric protein localization (GO:0008105) | 3.04644383 |
58 | gap junction assembly (GO:0016264) | 3.04537760 |
59 | negative regulation of axonogenesis (GO:0050771) | 3.04032680 |
60 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.03947176 |
61 | import into cell (GO:0098657) | 3.03179313 |
62 | COPII vesicle coating (GO:0048208) | 3.00099883 |
63 | photoreceptor cell differentiation (GO:0046530) | 2.99034976 |
64 | eye photoreceptor cell differentiation (GO:0001754) | 2.99034976 |
65 | response to lipoprotein particle (GO:0055094) | 2.95787308 |
66 | apical protein localization (GO:0045176) | 2.95116975 |
67 | magnesium ion transport (GO:0015693) | 2.92993070 |
68 | astrocyte development (GO:0014002) | 2.92221709 |
69 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.91137676 |
70 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.88635932 |
71 | low-density lipoprotein particle clearance (GO:0034383) | 2.88390583 |
72 | adult walking behavior (GO:0007628) | 2.88298760 |
73 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.87964220 |
74 | hypotonic response (GO:0006971) | 2.87330590 |
75 | neurotransmitter uptake (GO:0001504) | 2.86664395 |
76 | glutathione biosynthetic process (GO:0006750) | 2.85785216 |
77 | nerve growth factor signaling pathway (GO:0038180) | 2.85598414 |
78 | synaptic vesicle maturation (GO:0016188) | 2.83984953 |
79 | surfactant homeostasis (GO:0043129) | 2.83724947 |
80 | diterpenoid biosynthetic process (GO:0016102) | 2.82791485 |
81 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.79106826 |
82 | negative regulation of axon extension (GO:0030517) | 2.78850582 |
83 | transmission of nerve impulse (GO:0019226) | 2.78699543 |
84 | glomerular epithelial cell development (GO:0072310) | 2.77780295 |
85 | membrane protein ectodomain proteolysis (GO:0006509) | 2.75879151 |
86 | axon development (GO:0061564) | 2.75403580 |
87 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.75121105 |
88 | vesicle coating (GO:0006901) | 2.74999310 |
89 | regulation of water loss via skin (GO:0033561) | 2.73987767 |
90 | positive regulation of osteoblast proliferation (GO:0033690) | 2.73823349 |
91 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.73698874 |
92 | glomerular visceral epithelial cell development (GO:0072015) | 2.73378874 |
93 | muscle cell migration (GO:0014812) | 2.72385050 |
94 | locomotory exploration behavior (GO:0035641) | 2.71736365 |
95 | protein palmitoylation (GO:0018345) | 2.70929735 |
96 | dendritic spine morphogenesis (GO:0060997) | 2.67803106 |
97 | neuron recognition (GO:0008038) | 2.67478100 |
98 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.66878704 |
99 | protein maturation by protein folding (GO:0022417) | 2.66534143 |
100 | substrate-dependent cell migration (GO:0006929) | 2.65984235 |
101 | myelination in peripheral nervous system (GO:0022011) | 2.65043025 |
102 | peripheral nervous system axon ensheathment (GO:0032292) | 2.65043025 |
103 | glycosylceramide metabolic process (GO:0006677) | 2.63475776 |
104 | sodium ion export (GO:0071436) | 2.62998370 |
105 | apoptotic cell clearance (GO:0043277) | 2.62130039 |
106 | neuronal ion channel clustering (GO:0045161) | 2.62075227 |
107 | regulation of cardioblast differentiation (GO:0051890) | 2.61549245 |
108 | membrane tubulation (GO:0097320) | 2.60424688 |
109 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.59692123 |
110 | activation of Rac GTPase activity (GO:0032863) | 2.57863269 |
111 | regulation of transforming growth factor beta production (GO:0071634) | 2.57800592 |
112 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.57487381 |
113 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56649560 |
114 | multicellular organismal water homeostasis (GO:0050891) | 2.56347478 |
115 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.53406122 |
116 | cell volume homeostasis (GO:0006884) | 2.52793149 |
117 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.52364722 |
118 | response to hepatocyte growth factor (GO:0035728) | 2.51975893 |
119 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.51975893 |
120 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51745748 |
121 | detection of temperature stimulus (GO:0016048) | 2.51706858 |
122 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.50656134 |
123 | adherens junction assembly (GO:0034333) | 2.49101109 |
124 | axonal fasciculation (GO:0007413) | 2.47268323 |
125 | negative regulation of cell fate specification (GO:0009996) | 2.47256694 |
126 | lung epithelium development (GO:0060428) | 2.45688418 |
127 | dendrite morphogenesis (GO:0048813) | 2.45599852 |
128 | endodermal cell differentiation (GO:0035987) | 2.44045248 |
129 | peptidyl-cysteine modification (GO:0018198) | 2.43348197 |
130 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.42793765 |
131 | intestinal cholesterol absorption (GO:0030299) | 2.42622240 |
132 | regulation of metalloenzyme activity (GO:0048552) | 2.42468795 |
133 | barbed-end actin filament capping (GO:0051016) | 2.42374153 |
134 | adhesion of symbiont to host cell (GO:0044650) | 2.41799915 |
135 | virion attachment to host cell (GO:0019062) | 2.41799915 |
136 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41744936 |
137 | positive regulation of pseudopodium assembly (GO:0031274) | 2.41587958 |
138 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.41584820 |
139 | hippo signaling (GO:0035329) | 2.41283614 |
140 | peripheral nervous system development (GO:0007422) | 2.41250785 |
141 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.41159487 |
142 | enteric nervous system development (GO:0048484) | 2.41057647 |
143 | focal adhesion assembly (GO:0048041) | 2.39918897 |
144 | cell-substrate adherens junction assembly (GO:0007045) | 2.39918897 |
145 | basement membrane organization (GO:0071711) | 2.37930371 |
146 | regulation of axon regeneration (GO:0048679) | 2.37833126 |
147 | regulation of neuron projection regeneration (GO:0070570) | 2.37833126 |
148 | Golgi to endosome transport (GO:0006895) | 2.37457126 |
149 | L-serine transport (GO:0015825) | 2.36079658 |
150 | positive regulation of action potential (GO:0045760) | 2.35565540 |
151 | synaptic vesicle exocytosis (GO:0016079) | 2.35511232 |
152 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.35275422 |
153 | lung vasculature development (GO:0060426) | 2.35216326 |
154 | protein localization to endosome (GO:0036010) | 2.35127642 |
155 | peptide biosynthetic process (GO:0043043) | 2.34529344 |
156 | cell junction assembly (GO:0034329) | 2.34034195 |
157 | protein hydroxylation (GO:0018126) | 2.33814033 |
158 | membrane assembly (GO:0071709) | 2.33225649 |
159 | cellular potassium ion homeostasis (GO:0030007) | 2.32250888 |
160 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.32205904 |
161 | very long-chain fatty acid metabolic process (GO:0000038) | 2.32130324 |
162 | endocytic recycling (GO:0032456) | 2.31718877 |
163 | response to redox state (GO:0051775) | 2.31362054 |
164 | membrane budding (GO:0006900) | 2.31317908 |
165 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.30804389 |
166 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.30681204 |
167 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.30082832 |
168 | protein autoprocessing (GO:0016540) | 2.29946903 |
169 | cell-cell junction assembly (GO:0007043) | 2.29669265 |
170 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.29497618 |
171 | cellular response to epinephrine stimulus (GO:0071872) | 2.28750978 |
172 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.28710735 |
173 | glycine transport (GO:0015816) | 2.28218021 |
174 | cell junction organization (GO:0034330) | 2.28103962 |
175 | potassium ion import (GO:0010107) | 2.27739305 |
176 | copper ion homeostasis (GO:0055070) | 2.27409565 |
177 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.27084971 |
178 | renal filtration (GO:0097205) | 2.26938745 |
179 | ER overload response (GO:0006983) | 2.26594462 |
180 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.26043792 |
181 | cellular response to monoamine stimulus (GO:0071868) | 2.25857620 |
182 | cellular response to catecholamine stimulus (GO:0071870) | 2.25857620 |
183 | amyloid precursor protein catabolic process (GO:0042987) | 2.25797151 |
184 | cell junction maintenance (GO:0034331) | 2.25685943 |
185 | cell-cell junction maintenance (GO:0045217) | 2.25406058 |
186 | establishment of skin barrier (GO:0061436) | 2.24112299 |
187 | regulation of extracellular matrix organization (GO:1903053) | 2.22518688 |
188 | positive regulation of actin filament depolymerization (GO:0030836) | 2.22470958 |
189 | establishment of tissue polarity (GO:0007164) | 2.22368160 |
190 | establishment of planar polarity (GO:0001736) | 2.22368160 |
191 | mating behavior (GO:0007617) | 2.22294094 |
192 | negative regulation of anoikis (GO:2000811) | 2.22128193 |
193 | regulation of extracellular matrix disassembly (GO:0010715) | 2.21682047 |
194 | polarized epithelial cell differentiation (GO:0030859) | 2.20466672 |
195 | endothelial cell chemotaxis (GO:0035767) | 2.16787144 |
196 | intestinal epithelial cell development (GO:0060576) | 2.16420363 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.47507866 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.51359617 |
3 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.69100470 |
4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.05155610 |
5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.02299329 |
6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.01856783 |
7 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.93953843 |
8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70201787 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.68356926 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.62343072 |
11 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59488852 |
12 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.38883558 |
13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.37922527 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37305657 |
15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34791143 |
16 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.32481082 |
17 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.32481082 |
18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31237146 |
19 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.30884063 |
20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.29673128 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29310330 |
22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29310330 |
23 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21594479 |
24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.18820565 |
25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.18386733 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16887074 |
27 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.14848675 |
28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.10055655 |
29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.06178577 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03746804 |
31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.02024366 |
32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01262669 |
33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00729495 |
34 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.00268127 |
35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96805151 |
36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.94179109 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92740553 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91108801 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88034903 |
40 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87355442 |
41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87269937 |
42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.81843731 |
43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.81110480 |
44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78071177 |
45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76565199 |
46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76258760 |
47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74695499 |
48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74228130 |
49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70457220 |
50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.69031993 |
51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66388489 |
52 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.65790050 |
53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65567169 |
54 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.62035447 |
55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57586458 |
56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56962310 |
57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55813516 |
58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.54053430 |
59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.53718795 |
60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50913251 |
61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50569510 |
62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50095336 |
63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49300164 |
64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.47759715 |
65 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47743669 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47614533 |
67 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47166807 |
68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46409837 |
69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45802502 |
70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41257628 |
71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40776346 |
72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.39874777 |
73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39444506 |
74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39410944 |
75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37617658 |
76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36240621 |
77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35950460 |
78 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.35447370 |
79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.34878795 |
80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34626693 |
81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34122254 |
82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33400373 |
83 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32711141 |
84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31927820 |
85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31727373 |
86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31423830 |
87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31413911 |
88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31202431 |
89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30120730 |
90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30082091 |
91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29965012 |
92 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29513790 |
93 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28696366 |
94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27737723 |
95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.26386844 |
96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24927667 |
97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24630169 |
98 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24536579 |
99 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23950107 |
100 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23751974 |
101 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.23254956 |
102 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.22777792 |
103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22630209 |
104 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22325872 |
105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21518797 |
106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.21084484 |
107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20846756 |
108 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20661980 |
109 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20417968 |
110 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19561161 |
111 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18551554 |
112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18165603 |
113 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16942059 |
114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16406904 |
115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16240611 |
116 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15719997 |
117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.15558400 |
118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15074216 |
119 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13430464 |
120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13329869 |
121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13035213 |
122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12354189 |
123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12130632 |
124 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12041660 |
125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11135833 |
126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10550285 |
127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10174709 |
128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10060269 |
129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10060269 |
130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10053466 |
131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10053466 |
132 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09798127 |
133 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09347854 |
134 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08992987 |
135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08848077 |
136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08520996 |
137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08495352 |
138 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07018121 |
139 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06559259 |
140 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06424862 |
141 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05271711 |
142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04728752 |
143 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04465666 |
144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04319057 |
145 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04036653 |
146 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03567930 |
147 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03287590 |
148 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.02623593 |
149 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02386442 |
150 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02362468 |
151 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01304990 |
152 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01120972 |
153 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00675320 |
154 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00480186 |
155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00396225 |
156 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98826851 |
157 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98418041 |
158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97078891 |
159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96388560 |
160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96060072 |
161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95902434 |
162 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94494852 |
163 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93795930 |
164 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92656309 |
165 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91869992 |
166 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90841397 |
167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90736459 |
168 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90557423 |
169 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90337101 |
170 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90178070 |
171 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89879053 |
172 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89835770 |
173 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89562904 |
174 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88990347 |
175 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87073310 |
176 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86935778 |
177 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86234412 |
178 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85650830 |
179 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.85561325 |
180 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85205064 |
181 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.84592750 |
182 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83979064 |
183 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83546461 |
184 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82238749 |
185 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81494322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 4.74785706 |
2 | MP0000920_abnormal_myelination | 4.70011636 |
3 | MP0003880_abnormal_central_pattern | 3.85990605 |
4 | MP0004270_analgesia | 3.54243683 |
5 | MP0003566_abnormal_cell_adhesion | 3.50781577 |
6 | MP0004859_abnormal_synaptic_plasticity | 3.48733362 |
7 | MP0004885_abnormal_endolymph | 3.03728978 |
8 | MP0003690_abnormal_glial_cell | 2.89855240 |
9 | MP0000566_synostosis | 2.74616311 |
10 | MP0003329_amyloid_beta_deposits | 2.67069738 |
11 | MP0000579_abnormal_nail_morphology | 2.63854019 |
12 | MP0004043_abnormal_pH_regulation | 2.56186147 |
13 | MP0002064_seizures | 2.54480144 |
14 | MP0002272_abnormal_nervous_system | 2.51500533 |
15 | MP0004742_abnormal_vestibular_system | 2.44219107 |
16 | MP0003453_abnormal_keratinocyte_physiol | 2.43409329 |
17 | MP0001486_abnormal_startle_reflex | 2.42578934 |
18 | MP0010352_gastrointestinal_tract_polyps | 2.39307054 |
19 | MP0003635_abnormal_synaptic_transmissio | 2.36906448 |
20 | MP0004264_abnormal_extraembryonic_tissu | 2.36575604 |
21 | MP0003634_abnormal_glial_cell | 2.30670006 |
22 | MP0002796_impaired_skin_barrier | 2.26985776 |
23 | MP0005023_abnormal_wound_healing | 2.20275170 |
24 | MP0003941_abnormal_skin_development | 2.20151579 |
25 | MP0001485_abnormal_pinna_reflex | 2.17514757 |
26 | MP0004858_abnormal_nervous_system | 2.16541603 |
27 | MP0000778_abnormal_nervous_system | 2.16248117 |
28 | MP0009840_abnormal_foam_cell | 2.15250122 |
29 | MP0003705_abnormal_hypodermis_morpholog | 2.15037208 |
30 | MP0005257_abnormal_intraocular_pressure | 2.14675935 |
31 | MP0009745_abnormal_behavioral_response | 2.10749037 |
32 | MP0001905_abnormal_dopamine_level | 2.09842068 |
33 | MP0004142_abnormal_muscle_tone | 2.06383792 |
34 | MP0002734_abnormal_mechanical_nocicepti | 2.05714590 |
35 | MP0002060_abnormal_skin_morphology | 2.03192589 |
36 | MP0001968_abnormal_touch/_nociception | 1.95029621 |
37 | MP0000467_abnormal_esophagus_morphology | 1.94978304 |
38 | MP0000537_abnormal_urethra_morphology | 1.94325015 |
39 | MP0005409_darkened_coat_color | 1.93922338 |
40 | MP0002735_abnormal_chemical_nociception | 1.93453603 |
41 | MP0005171_absent_coat_pigmentation | 1.89246504 |
42 | MP0002877_abnormal_melanocyte_morpholog | 1.83847945 |
43 | MP0002063_abnormal_learning/memory/cond | 1.82457516 |
44 | MP0001849_ear_inflammation | 1.80524945 |
45 | MP0009046_muscle_twitch | 1.76688664 |
46 | MP0001216_abnormal_epidermal_layer | 1.76137055 |
47 | MP0005423_abnormal_somatic_nervous | 1.74157300 |
48 | MP0001529_abnormal_vocalization | 1.71490488 |
49 | MP0001970_abnormal_pain_threshold | 1.70338961 |
50 | MP0005058_abnormal_lysosome_morphology | 1.69607336 |
51 | MP0002736_abnormal_nociception_after | 1.68165865 |
52 | MP0002572_abnormal_emotion/affect_behav | 1.66443227 |
53 | MP0002229_neurodegeneration | 1.66436433 |
54 | MP0003191_abnormal_cellular_cholesterol | 1.64614461 |
55 | MP0003091_abnormal_cell_migration | 1.56692745 |
56 | MP0003633_abnormal_nervous_system | 1.56673764 |
57 | MP0002733_abnormal_thermal_nociception | 1.55510300 |
58 | MP0008438_abnormal_cutaneous_collagen | 1.54602963 |
59 | MP0004147_increased_porphyrin_level | 1.53975675 |
60 | MP0002067_abnormal_sensory_capabilities | 1.52646805 |
61 | MP0000955_abnormal_spinal_cord | 1.49991450 |
62 | MP0000604_amyloidosis | 1.48407626 |
63 | MP0003631_nervous_system_phenotype | 1.45988658 |
64 | MP0003632_abnormal_nervous_system | 1.45805409 |
65 | MP0005501_abnormal_skin_physiology | 1.45010348 |
66 | MP0003283_abnormal_digestive_organ | 1.44257066 |
67 | MP0002098_abnormal_vibrissa_morphology | 1.43658814 |
68 | MP0001765_abnormal_ion_homeostasis | 1.42361057 |
69 | MP0009053_abnormal_anal_canal | 1.41867092 |
70 | MP0003136_yellow_coat_color | 1.41573771 |
71 | MP0001963_abnormal_hearing_physiology | 1.41281856 |
72 | MP0001440_abnormal_grooming_behavior | 1.41132753 |
73 | MP0000462_abnormal_digestive_system | 1.40895669 |
74 | MP0005076_abnormal_cell_differentiation | 1.38733769 |
75 | MP0002882_abnormal_neuron_morphology | 1.37486234 |
76 | MP0003172_abnormal_lysosome_physiology | 1.36752740 |
77 | MP0002896_abnormal_bone_mineralization | 1.33215393 |
78 | MP0005165_increased_susceptibility_to | 1.33164850 |
79 | MP0002066_abnormal_motor_capabilities/c | 1.31895758 |
80 | MP0000003_abnormal_adipose_tissue | 1.28693803 |
81 | MP0003075_altered_response_to | 1.28032907 |
82 | MP0003123_paternal_imprinting | 1.27900607 |
83 | MP0003195_calcinosis | 1.25472528 |
84 | MP0005670_abnormal_white_adipose | 1.25251294 |
85 | MP0004782_abnormal_surfactant_physiolog | 1.23857131 |
86 | MP0003950_abnormal_plasma_membrane | 1.23620137 |
87 | MP0010030_abnormal_orbit_morphology | 1.22334814 |
88 | MP0010368_abnormal_lymphatic_system | 1.22235010 |
89 | MP0001958_emphysema | 1.22169853 |
90 | MP0005623_abnormal_meninges_morphology | 1.21125720 |
91 | MP0010771_integument_phenotype | 1.18679096 |
92 | MP0002909_abnormal_adrenal_gland | 1.18628330 |
93 | MP0005275_abnormal_skin_tensile | 1.18381837 |
94 | MP0004185_abnormal_adipocyte_glucose | 1.18369422 |
95 | MP0002089_abnormal_postnatal_growth/wei | 1.17301575 |
96 | MP0010678_abnormal_skin_adnexa | 1.16838625 |
97 | MP0008569_lethality_at_weaning | 1.16316934 |
98 | MP0000678_abnormal_parathyroid_gland | 1.16257343 |
99 | MP0005164_abnormal_response_to | 1.15158447 |
100 | MP0001915_intracranial_hemorrhage | 1.14395574 |
101 | MP0000747_muscle_weakness | 1.10366232 |
102 | MP0005666_abnormal_adipose_tissue | 1.09889800 |
103 | MP0001501_abnormal_sleep_pattern | 1.05044169 |
104 | MP0002752_abnormal_somatic_nervous | 1.04743697 |
105 | MP0006276_abnormal_autonomic_nervous | 1.02922552 |
106 | MP0001984_abnormal_olfaction | 1.02902469 |
107 | MP0004134_abnormal_chest_morphology | 1.02563360 |
108 | MP0006054_spinal_hemorrhage | 1.01894953 |
109 | MP0005375_adipose_tissue_phenotype | 1.01343015 |
110 | MP0003868_abnormal_feces_composition | 1.00135923 |
111 | MP0004811_abnormal_neuron_physiology | 0.99173906 |
112 | MP0001299_abnormal_eye_distance/ | 0.98966432 |
113 | MP0002557_abnormal_social/conspecific_i | 0.97177825 |
114 | MP0004924_abnormal_behavior | 0.95149149 |
115 | MP0005386_behavior/neurological_phenoty | 0.95149149 |
116 | MP0005365_abnormal_bile_salt | 0.94800119 |
117 | MP0001664_abnormal_digestion | 0.94351540 |
118 | MP0002184_abnormal_innervation | 0.94087126 |
119 | MP0008260_abnormal_autophagy | 0.92596319 |
120 | MP0000377_abnormal_hair_follicle | 0.91446443 |
121 | MP0005451_abnormal_body_composition | 0.90449404 |
122 | MP0001177_atelectasis | 0.90258947 |
123 | MP0005197_abnormal_uvea_morphology | 0.88698473 |
124 | MP0000627_abnormal_mammary_gland | 0.87331694 |
125 | MP0003300_gastrointestinal_ulcer | 0.86852475 |
126 | MP0000858_altered_metastatic_potential | 0.86350074 |
127 | MP0001666_abnormal_nutrient_absorption | 0.86332573 |
128 | MP0002234_abnormal_pharynx_morphology | 0.85318690 |
129 | MP0005410_abnormal_fertilization | 0.84313898 |
130 | MP0003122_maternal_imprinting | 0.84073549 |
131 | MP0002152_abnormal_brain_morphology | 0.84056411 |
132 | MP0004019_abnormal_vitamin_homeostasis | 0.83694389 |
133 | MP0001851_eye_inflammation | 0.82779600 |
134 | MP0000751_myopathy | 0.82776778 |
135 | MP0003183_abnormal_peptide_metabolism | 0.82403490 |
136 | MP0000465_gastrointestinal_hemorrhage | 0.81511909 |
137 | MP0004510_myositis | 0.81372272 |
138 | MP0001661_extended_life_span | 0.81158611 |
139 | MP0004233_abnormal_muscle_weight | 0.79756905 |
140 | MP0000026_abnormal_inner_ear | 0.79009679 |
141 | MP0005367_renal/urinary_system_phenotyp | 0.78436679 |
142 | MP0000516_abnormal_urinary_system | 0.78436679 |
143 | MP0005551_abnormal_eye_electrophysiolog | 0.78020000 |
144 | MP0002139_abnormal_hepatobiliary_system | 0.76596458 |
145 | MP0003315_abnormal_perineum_morphology | 0.76030811 |
146 | MP0005388_respiratory_system_phenotype | 0.74102754 |
147 | MP0002133_abnormal_respiratory_system | 0.74102754 |
148 | MP0005636_abnormal_mineral_homeostasis | 0.73498283 |
149 | MP0003385_abnormal_body_wall | 0.72967309 |
150 | MP0005310_abnormal_salivary_gland | 0.70211777 |
151 | MP0005195_abnormal_posterior_eye | 0.69473698 |
152 | MP0003938_abnormal_ear_development | 0.68802453 |
153 | MP0002697_abnormal_eye_size | 0.68548701 |
154 | MP0005332_abnormal_amino_acid | 0.68485877 |
155 | MP0001614_abnormal_blood_vessel | 0.68334199 |
156 | MP0003115_abnormal_respiratory_system | 0.67277893 |
157 | MP0002925_abnormal_cardiovascular_devel | 0.67173909 |
158 | MP0002233_abnormal_nose_morphology | 0.66488159 |
159 | MP0006138_congestive_heart_failure | 0.66452482 |
160 | MP0000230_abnormal_systemic_arterial | 0.66327033 |
161 | MP0005508_abnormal_skeleton_morphology | 0.66204621 |
162 | MP0002086_abnormal_extraembryonic_tissu | 0.65374121 |
163 | MP0009643_abnormal_urine_homeostasis | 0.65316944 |
164 | MP0005621_abnormal_cell_physiology | 0.64594666 |
165 | MP0005083_abnormal_biliary_tract | 0.64533976 |
166 | MP0005645_abnormal_hypothalamus_physiol | 0.64461571 |
167 | MP0004272_abnormal_basement_membrane | 0.64286485 |
168 | MP0009780_abnormal_chondrocyte_physiolo | 0.63688475 |
169 | MP0003119_abnormal_digestive_system | 0.63313200 |
170 | MP0000383_abnormal_hair_follicle | 0.62948907 |
171 | MP0000647_abnormal_sebaceous_gland | 0.62267657 |
172 | MP0000013_abnormal_adipose_tissue | 0.61281773 |
173 | MP0003890_abnormal_embryonic-extraembry | 0.61173799 |
174 | MP0000762_abnormal_tongue_morphology | 0.60885199 |
175 | MP0000733_abnormal_muscle_development | 0.59987110 |
176 | MP0002295_abnormal_pulmonary_circulatio | 0.59835274 |
177 | MP0005381_digestive/alimentary_phenotyp | 0.59345294 |
178 | MP0002090_abnormal_vision | 0.59223348 |
179 | MP0000534_abnormal_ureter_morphology | 0.58990511 |
180 | MP0005377_hearing/vestibular/ear_phenot | 0.57812937 |
181 | MP0003878_abnormal_ear_physiology | 0.57812937 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.49349979 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.49349979 |
3 | Increased circulating renin level (HP:0000848) | 5.39367647 |
4 | Neurofibrillary tangles (HP:0002185) | 5.33783507 |
5 | Metabolic alkalosis (HP:0200114) | 4.98526713 |
6 | Hypomagnesemia (HP:0002917) | 4.93592595 |
7 | Hypokalemic alkalosis (HP:0001949) | 4.64045854 |
8 | Atrophic scars (HP:0001075) | 4.46899920 |
9 | Right ventricular cardiomyopathy (HP:0011663) | 4.32389699 |
10 | Abnormality of the corticospinal tract (HP:0002492) | 4.23559765 |
11 | Abnormality of magnesium homeostasis (HP:0004921) | 4.17048829 |
12 | Supranuclear gaze palsy (HP:0000605) | 4.11010130 |
13 | Cerebral inclusion bodies (HP:0100314) | 4.08292848 |
14 | Peripheral hypomyelination (HP:0007182) | 3.97711419 |
15 | Milia (HP:0001056) | 3.79630405 |
16 | Arterial tortuosity (HP:0005116) | 3.62764371 |
17 | Fragile nails (HP:0001808) | 3.58414431 |
18 | Myokymia (HP:0002411) | 3.54726928 |
19 | Onycholysis (HP:0001806) | 3.53584646 |
20 | Termporal pattern (HP:0011008) | 3.50212702 |
21 | Insidious onset (HP:0003587) | 3.50212702 |
22 | Sensory axonal neuropathy (HP:0003390) | 3.38812033 |
23 | Retinal dysplasia (HP:0007973) | 3.34232819 |
24 | Onion bulb formation (HP:0003383) | 3.32383800 |
25 | Polyuria (HP:0000103) | 3.31164447 |
26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.28036613 |
27 | Plantar hyperkeratosis (HP:0007556) | 3.25307922 |
28 | Spastic gait (HP:0002064) | 3.20598704 |
29 | Intention tremor (HP:0002080) | 3.17742443 |
30 | Abnormal drinking behavior (HP:0030082) | 3.14104266 |
31 | Polydipsia (HP:0001959) | 3.14104266 |
32 | Abnormality of chloride homeostasis (HP:0011422) | 3.14050269 |
33 | Hyperactive renin-angiotensin system (HP:0000841) | 3.12744510 |
34 | Vascular tortuosity (HP:0004948) | 3.09663827 |
35 | Alopecia of scalp (HP:0002293) | 3.07096623 |
36 | Premature rupture of membranes (HP:0001788) | 3.06090832 |
37 | Parakeratosis (HP:0001036) | 3.05729181 |
38 | Abnormal urine output (HP:0012590) | 3.04227382 |
39 | Vascular calcification (HP:0004934) | 2.99936102 |
40 | Short nail (HP:0001799) | 2.98314147 |
41 | Hyperaldosteronism (HP:0000859) | 2.96885771 |
42 | Renal salt wasting (HP:0000127) | 2.92841426 |
43 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.92435749 |
44 | Abnormality of renin-angiotensin system (HP:0000847) | 2.91517442 |
45 | Pterygium (HP:0001059) | 2.91254675 |
46 | Abnormality of renal excretion (HP:0011036) | 2.89340600 |
47 | Dysmetria (HP:0001310) | 2.87541748 |
48 | Abnormal auditory evoked potentials (HP:0006958) | 2.86786086 |
49 | Flat acetabular roof (HP:0003180) | 2.83135454 |
50 | Focal segmental glomerulosclerosis (HP:0000097) | 2.82508002 |
51 | Ankle clonus (HP:0011448) | 2.80375692 |
52 | Ankyloglossia (HP:0010296) | 2.73566503 |
53 | Cardiovascular calcification (HP:0011915) | 2.67926198 |
54 | Fragile skin (HP:0001030) | 2.66145292 |
55 | Hypoplasia of dental enamel (HP:0006297) | 2.65937119 |
56 | Protrusio acetabuli (HP:0003179) | 2.62622017 |
57 | Thick nail (HP:0001805) | 2.58848688 |
58 | Popliteal pterygium (HP:0009756) | 2.56382943 |
59 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.54895650 |
60 | Increased serum pyruvate (HP:0003542) | 2.50379555 |
61 | Abnormality of glycolysis (HP:0004366) | 2.50379555 |
62 | Focal motor seizures (HP:0011153) | 2.47064022 |
63 | Broad face (HP:0000283) | 2.46722581 |
64 | Hypoplasia of the iris (HP:0007676) | 2.46681201 |
65 | Distal upper limb amyotrophy (HP:0007149) | 2.45986511 |
66 | Upper limb amyotrophy (HP:0009129) | 2.45986511 |
67 | Akinesia (HP:0002304) | 2.45399254 |
68 | Glomerulosclerosis (HP:0000096) | 2.44965840 |
69 | Pheochromocytoma (HP:0002666) | 2.44037131 |
70 | Nail dystrophy (HP:0008404) | 2.43760754 |
71 | Morphological abnormality of the inner ear (HP:0011390) | 2.43289430 |
72 | Action tremor (HP:0002345) | 2.42212100 |
73 | Pili torti (HP:0003777) | 2.37801251 |
74 | Cervical subluxation (HP:0003308) | 2.35769835 |
75 | Stridor (HP:0010307) | 2.35285320 |
76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.35191521 |
77 | Scanning speech (HP:0002168) | 2.34930809 |
78 | Slow saccadic eye movements (HP:0000514) | 2.33921170 |
79 | Tetany (HP:0001281) | 2.32875781 |
80 | Deep venous thrombosis (HP:0002625) | 2.30871713 |
81 | Advanced eruption of teeth (HP:0006288) | 2.29380753 |
82 | Cerebral hemorrhage (HP:0001342) | 2.28090317 |
83 | Abnormality of carpal bone ossification (HP:0006257) | 2.26024794 |
84 | Cerebral hypomyelination (HP:0006808) | 2.25728476 |
85 | Abnormal eating behavior (HP:0100738) | 2.22776408 |
86 | Autoamputation (HP:0001218) | 2.21718398 |
87 | Palmoplantar hyperkeratosis (HP:0000972) | 2.20916777 |
88 | Vertebral compression fractures (HP:0002953) | 2.20605076 |
89 | Partial agenesis of the corpus callosum (HP:0001338) | 2.20536834 |
90 | Back pain (HP:0003418) | 2.18672318 |
91 | Urinary urgency (HP:0000012) | 2.17661867 |
92 | Alacrima (HP:0000522) | 2.17008956 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15305381 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 2.15305381 |
95 | Natal tooth (HP:0000695) | 2.14325052 |
96 | Ridged nail (HP:0001807) | 2.14134140 |
97 | Distal lower limb amyotrophy (HP:0008944) | 2.12825080 |
98 | Alkalosis (HP:0001948) | 2.10925055 |
99 | Clumsiness (HP:0002312) | 2.08293741 |
100 | Axonal loss (HP:0003447) | 2.08226768 |
101 | Abnormality of oral frenula (HP:0000190) | 2.07196272 |
102 | Trismus (HP:0000211) | 2.07190901 |
103 | Tetraparesis (HP:0002273) | 2.07081026 |
104 | Vacuolated lymphocytes (HP:0001922) | 2.06754688 |
105 | Palmar hyperkeratosis (HP:0010765) | 2.05114026 |
106 | Premature skin wrinkling (HP:0100678) | 2.04477648 |
107 | Bronchomalacia (HP:0002780) | 2.03318450 |
108 | Hand muscle atrophy (HP:0009130) | 2.01876006 |
109 | Lower limb muscle weakness (HP:0007340) | 2.01471966 |
110 | Neonatal death (HP:0003811) | 2.00257147 |
111 | Ulnar claw (HP:0001178) | 2.00156992 |
112 | Hypokalemia (HP:0002900) | 1.99264326 |
113 | Small epiphyses (HP:0010585) | 1.98614565 |
114 | Absent eyelashes (HP:0000561) | 1.98013157 |
115 | Neuroendocrine neoplasm (HP:0100634) | 1.97867169 |
116 | Acanthosis nigricans (HP:0000956) | 1.97501504 |
117 | Patchy hypopigmentation of hair (HP:0011365) | 1.96358174 |
118 | Nuclear cataract (HP:0100018) | 1.94634107 |
119 | Leukodystrophy (HP:0002415) | 1.92369988 |
120 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.92008226 |
121 | Vertebral hypoplasia (HP:0008417) | 1.92008226 |
122 | Spastic paraparesis (HP:0002313) | 1.91985366 |
123 | Abnormal ossification of hand bones (HP:0005921) | 1.91542161 |
124 | Hyperacusis (HP:0010780) | 1.91501881 |
125 | Abnormality of the gastric mucosa (HP:0004295) | 1.90278446 |
126 | Dysostosis multiplex (HP:0000943) | 1.89926493 |
127 | Selective tooth agenesis (HP:0001592) | 1.89664856 |
128 | Distal lower limb muscle weakness (HP:0009053) | 1.88964024 |
129 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88902410 |
130 | Hemorrhage of the eye (HP:0011885) | 1.88491627 |
131 | Hypoplastic pelvis (HP:0008839) | 1.87926813 |
132 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.87670797 |
133 | Abnormality of nail color (HP:0100643) | 1.87430289 |
134 | Type II lissencephaly (HP:0007260) | 1.86356584 |
135 | Atonic seizures (HP:0010819) | 1.86217832 |
136 | Foot dorsiflexor weakness (HP:0009027) | 1.85004302 |
137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84310894 |
138 | Abnormal hair laboratory examination (HP:0003328) | 1.84214976 |
139 | Hypercholesterolemia (HP:0003124) | 1.83950881 |
140 | Focal seizures (HP:0007359) | 1.82614058 |
141 | Abnormal blistering of the skin (HP:0008066) | 1.80667853 |
142 | Skin nodule (HP:0200036) | 1.79881979 |
143 | Thickened helices (HP:0000391) | 1.79392543 |
144 | Coxa vara (HP:0002812) | 1.78617455 |
145 | Mutism (HP:0002300) | 1.77842375 |
146 | Hammertoe (HP:0001765) | 1.76347342 |
147 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76032636 |
148 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76032636 |
149 | Aplasia involving bones of the extremities (HP:0009825) | 1.76032636 |
150 | Barrel-shaped chest (HP:0001552) | 1.75484833 |
151 | Polyphagia (HP:0002591) | 1.75319128 |
152 | Anteriorly placed anus (HP:0001545) | 1.74905569 |
153 | Synostosis involving the elbow (HP:0003938) | 1.74638015 |
154 | Humeroradial synostosis (HP:0003041) | 1.74638015 |
155 | Abnormality of potassium homeostasis (HP:0011042) | 1.74469653 |
156 | White forelock (HP:0002211) | 1.74328419 |
157 | Hyperparathyroidism (HP:0000843) | 1.74196146 |
158 | Mucopolysacchariduria (HP:0008155) | 1.73591586 |
159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73591586 |
160 | Mitral stenosis (HP:0001718) | 1.73457651 |
161 | Abnormality of permanent molar morphology (HP:0011071) | 1.71993621 |
162 | Abnormality of the dental root (HP:0006486) | 1.71993621 |
163 | Taurodontia (HP:0000679) | 1.71993621 |
164 | Esophageal atresia (HP:0002032) | 1.71801412 |
165 | Psychosis (HP:0000709) | 1.70944422 |
166 | Neuronal loss in central nervous system (HP:0002529) | 1.70578697 |
167 | Sparse eyelashes (HP:0000653) | 1.70424982 |
168 | Spinal cord compression (HP:0002176) | 1.69357642 |
169 | Insulin resistance (HP:0000855) | 1.69125002 |
170 | Flattened epiphyses (HP:0003071) | 1.68054136 |
171 | Spastic tetraparesis (HP:0001285) | 1.67765041 |
172 | Hypercalciuria (HP:0002150) | 1.66896765 |
173 | Urinary incontinence (HP:0000020) | 1.66617642 |
174 | Abnormal hand bone ossification (HP:0010660) | 1.66230254 |
175 | Cerebral aneurysm (HP:0004944) | 1.65784504 |
176 | Delayed epiphyseal ossification (HP:0002663) | 1.65538975 |
177 | Xanthomatosis (HP:0000991) | 1.64917147 |
178 | Abnormality of the Achilles tendon (HP:0005109) | 1.64750946 |
179 | Lower limb amyotrophy (HP:0007210) | 1.64513732 |
180 | Epiphyseal dysplasia (HP:0002656) | 1.64308140 |
181 | Anxiety (HP:0000739) | 1.64099092 |
182 | CNS hypomyelination (HP:0003429) | 1.63903709 |
183 | Abnormal tarsal ossification (HP:0008369) | 1.63423899 |
184 | Megalencephaly (HP:0001355) | 1.62766809 |
185 | Distal sensory impairment (HP:0002936) | 1.62608326 |
186 | Ulnar bowing (HP:0003031) | 1.62529599 |
187 | Loss of speech (HP:0002371) | 1.61778725 |
188 | Shallow orbits (HP:0000586) | 1.61707647 |
189 | Growth hormone excess (HP:0000845) | 1.61325504 |
190 | Hypoalphalipoproteinemia (HP:0003233) | 1.60734843 |
191 | Peripheral demyelination (HP:0011096) | 1.60680767 |
192 | Progressive sensorineural hearing impairment (HP:0000408) | 1.60408264 |
193 | Deviation of the thumb (HP:0009603) | 1.60148792 |
194 | Achilles tendon contracture (HP:0001771) | 1.59809766 |
195 | Vertebral clefting (HP:0008428) | 1.59641564 |
196 | Epileptic encephalopathy (HP:0200134) | 1.59617001 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 6.81028514 |
2 | STK39 | 6.75630705 |
3 | MST1R | 5.70546741 |
4 | OXSR1 | 5.61973456 |
5 | WNK4 | 4.16563033 |
6 | LMTK2 | 3.73879711 |
7 | EPHB1 | 3.44778133 |
8 | RIPK1 | 2.63435871 |
9 | TESK1 | 2.46643784 |
10 | MAPKAPK5 | 2.43233441 |
11 | PTK2 | 2.34868793 |
12 | NTRK1 | 2.33090919 |
13 | IRAK3 | 2.32508925 |
14 | TNIK | 2.18532790 |
15 | LATS2 | 2.13654120 |
16 | EPHB2 | 2.12388039 |
17 | PAK4 | 2.09839692 |
18 | PDGFRA | 2.03900157 |
19 | WNK1 | 1.98406330 |
20 | SIK1 | 1.96452006 |
21 | WNK3 | 1.93142659 |
22 | PKN1 | 1.84485666 |
23 | CDK19 | 1.81154408 |
24 | MST4 | 1.78922071 |
25 | LATS1 | 1.66028262 |
26 | LIMK1 | 1.62000523 |
27 | UHMK1 | 1.57437683 |
28 | PNCK | 1.46062023 |
29 | BCR | 1.45601342 |
30 | ERN1 | 1.44481387 |
31 | MARK1 | 1.44095685 |
32 | MAP3K3 | 1.37101990 |
33 | FGFR2 | 1.36077869 |
34 | FGR | 1.35606480 |
35 | CSNK1G3 | 1.34041097 |
36 | PAK6 | 1.31600503 |
37 | EPHA4 | 1.25762704 |
38 | FES | 1.23627112 |
39 | SGK494 | 1.22924690 |
40 | SGK223 | 1.22924690 |
41 | MET | 1.22302435 |
42 | CSNK1A1L | 1.21790763 |
43 | CASK | 1.20288358 |
44 | ICK | 1.19559473 |
45 | ROCK2 | 1.19422380 |
46 | CAMK2B | 1.19416080 |
47 | NME2 | 1.16814304 |
48 | TESK2 | 1.16593649 |
49 | TYRO3 | 1.13823603 |
50 | CSNK1G2 | 1.10978313 |
51 | NTRK3 | 1.08675432 |
52 | MINK1 | 1.08520454 |
53 | STK38 | 1.07849193 |
54 | CLK1 | 1.04071023 |
55 | SCYL2 | 1.02317396 |
56 | CDK12 | 1.01602380 |
57 | CSNK1G1 | 1.00044908 |
58 | STK38L | 0.99168895 |
59 | CDK5 | 0.98847067 |
60 | IRAK2 | 0.98623316 |
61 | TRIB3 | 0.97792732 |
62 | MAP3K2 | 0.96024159 |
63 | CAMK2D | 0.95270872 |
64 | SMG1 | 0.95081753 |
65 | DDR2 | 0.94783320 |
66 | BMX | 0.94618415 |
67 | KSR2 | 0.93664959 |
68 | PAK3 | 0.89919182 |
69 | MAPK15 | 0.89657874 |
70 | PBK | 0.89032867 |
71 | TGFBR2 | 0.85551326 |
72 | FGFR4 | 0.85551163 |
73 | STK24 | 0.84413514 |
74 | MAP2K2 | 0.82579211 |
75 | PTK6 | 0.81932879 |
76 | MAP3K9 | 0.80588702 |
77 | CDK8 | 0.78050163 |
78 | CAMK2A | 0.77196865 |
79 | NEK6 | 0.75978270 |
80 | GRK7 | 0.75165652 |
81 | CAMK1G | 0.75016587 |
82 | CAMK2G | 0.74709306 |
83 | PIM2 | 0.72926214 |
84 | MAPK13 | 0.72129371 |
85 | CDK14 | 0.71545701 |
86 | PDPK1 | 0.70950658 |
87 | PHKG2 | 0.70651367 |
88 | PHKG1 | 0.70651367 |
89 | ARAF | 0.70211794 |
90 | MARK2 | 0.69432772 |
91 | NTRK2 | 0.69146819 |
92 | GRK5 | 0.66792738 |
93 | CAMK1D | 0.64401153 |
94 | PDGFRB | 0.63804094 |
95 | MTOR | 0.63634406 |
96 | PRKG2 | 0.63520865 |
97 | FYN | 0.60609326 |
98 | RIPK4 | 0.59957187 |
99 | CDK15 | 0.58812911 |
100 | PRKCE | 0.57966975 |
101 | PRKCQ | 0.57865252 |
102 | MUSK | 0.57315051 |
103 | CDK18 | 0.56298626 |
104 | MATK | 0.54169470 |
105 | DYRK2 | 0.54098757 |
106 | GSK3A | 0.53080963 |
107 | MAP3K12 | 0.52566860 |
108 | CDK11A | 0.51644322 |
109 | PDK1 | 0.50975351 |
110 | CDK9 | 0.49775834 |
111 | DMPK | 0.48959039 |
112 | FLT3 | 0.48448096 |
113 | STK11 | 0.48405855 |
114 | TRPM7 | 0.47845917 |
115 | MAP3K4 | 0.47639740 |
116 | DAPK1 | 0.46153708 |
117 | PRPF4B | 0.45511578 |
118 | PRKD1 | 0.45274053 |
119 | BLK | 0.45242478 |
120 | FGFR1 | 0.44446691 |
121 | CDC42BPA | 0.43906651 |
122 | NME1 | 0.41467061 |
123 | PTK2B | 0.40793618 |
124 | IRAK1 | 0.40407106 |
125 | SGK3 | 0.39787362 |
126 | FER | 0.37617324 |
127 | MAP3K1 | 0.37396395 |
128 | PIK3CA | 0.34794033 |
129 | BRAF | 0.34259851 |
130 | FGFR3 | 0.34106458 |
131 | RET | 0.33943294 |
132 | PLK2 | 0.33851918 |
133 | MAP3K13 | 0.33495956 |
134 | MYLK | 0.33458683 |
135 | SGK1 | 0.33020637 |
136 | TTN | 0.32285705 |
137 | STK10 | 0.32173445 |
138 | ERBB4 | 0.30777247 |
139 | PRKG1 | 0.30709763 |
140 | PRKACB | 0.29849597 |
141 | CSF1R | 0.29089013 |
142 | PRKCI | 0.28679253 |
143 | PRKD3 | 0.28624487 |
144 | MAP2K7 | 0.27999256 |
145 | PKN2 | 0.27750950 |
146 | CSNK1A1 | 0.27179883 |
147 | MOS | 0.26743957 |
148 | ROCK1 | 0.26717629 |
149 | ABL2 | 0.25828494 |
150 | BMPR1B | 0.25672462 |
151 | SRC | 0.25196958 |
152 | TNK2 | 0.25036967 |
153 | MAP2K1 | 0.24882307 |
154 | KSR1 | 0.24800277 |
155 | ILK | 0.23612190 |
156 | RPS6KA2 | 0.22591915 |
157 | SIK3 | 0.21885164 |
158 | MAP3K8 | 0.21008078 |
159 | ERBB2 | 0.20734572 |
160 | STK3 | 0.19415759 |
161 | ERBB3 | 0.19316908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.43590232 |
2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.39153979 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.13973067 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.79283135 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.37266209 |
6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.33266209 |
7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.33255054 |
8 | Adherens junction_Homo sapiens_hsa04520 | 2.21913580 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03923500 |
10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.97346507 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.93792179 |
12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.89101881 |
13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.82828408 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69537153 |
15 | Focal adhesion_Homo sapiens_hsa04510 | 1.67087678 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65329728 |
17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63736120 |
18 | Axon guidance_Homo sapiens_hsa04360 | 1.60795657 |
19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.57880330 |
20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.57225427 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54985165 |
22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54622253 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52241565 |
24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49149502 |
25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.48888654 |
26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46879132 |
27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45262556 |
28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.44490516 |
29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.43363604 |
30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42488898 |
31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37155717 |
32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.35754581 |
33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.34496483 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31901130 |
35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31415228 |
36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.29278037 |
37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.29233047 |
38 | Salivary secretion_Homo sapiens_hsa04970 | 1.28727185 |
39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23637766 |
40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22268133 |
41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22203741 |
42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19668775 |
43 | Long-term depression_Homo sapiens_hsa04730 | 1.18493138 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18343590 |
45 | Lysosome_Homo sapiens_hsa04142 | 1.18246589 |
46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17783806 |
47 | Amoebiasis_Homo sapiens_hsa05146 | 1.16402904 |
48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15727464 |
49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15432655 |
50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14245738 |
51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13531121 |
52 | Morphine addiction_Homo sapiens_hsa05032 | 1.13479655 |
53 | Bladder cancer_Homo sapiens_hsa05219 | 1.13024975 |
54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09084059 |
55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09008091 |
56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08599318 |
57 | Prion diseases_Homo sapiens_hsa05020 | 1.06422225 |
58 | Mineral absorption_Homo sapiens_hsa04978 | 1.05426389 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04208569 |
60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01394855 |
61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.00878510 |
62 | Nicotine addiction_Homo sapiens_hsa05033 | 1.00631847 |
63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00341358 |
64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.00172629 |
65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00118900 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97640647 |
67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97462920 |
68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97227264 |
69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95656546 |
70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95097433 |
71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94134931 |
72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93874172 |
73 | Renin secretion_Homo sapiens_hsa04924 | 0.93587423 |
74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90137223 |
75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90080659 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89935353 |
77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89828848 |
78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88414861 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88021566 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86968574 |
81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85245864 |
82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84951021 |
83 | Bile secretion_Homo sapiens_hsa04976 | 0.84665613 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82789968 |
85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82631045 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.82378373 |
87 | Gap junction_Homo sapiens_hsa04540 | 0.82062734 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81597196 |
89 | Phagosome_Homo sapiens_hsa04145 | 0.81521955 |
90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81351532 |
91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79793035 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79417969 |
93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79075968 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78717808 |
95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78442227 |
96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78008999 |
97 | Tight junction_Homo sapiens_hsa04530 | 0.77480051 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75191450 |
99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74647192 |
100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74212406 |
101 | Taste transduction_Homo sapiens_hsa04742 | 0.73480512 |
102 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73303238 |
103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73086515 |
104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72193956 |
105 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71929161 |
106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71681470 |
107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71575455 |
108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71075365 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70996925 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70464197 |
111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69778916 |
112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69093855 |
113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68523526 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67473497 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65779273 |
116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64593760 |
117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63835297 |
118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63456615 |
119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63410622 |
120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63127271 |
121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62641848 |
122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62341527 |
123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62051828 |
124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61442375 |
125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61297201 |
126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60453439 |
127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60424151 |
128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60410075 |
129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59793717 |
130 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59442295 |
131 | Protein export_Homo sapiens_hsa03060 | 0.59211919 |
132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58500207 |
133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58075510 |
134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57979912 |
135 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57582134 |
136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57273713 |
137 | Salmonella infection_Homo sapiens_hsa05132 | 0.56334583 |
138 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56055555 |
139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55469452 |
140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55087177 |
141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55001192 |
142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54887813 |
143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54363775 |
144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54012766 |
145 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53925372 |
146 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53340179 |
147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52890870 |
148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52280592 |
149 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52132865 |
150 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51700351 |
151 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51366599 |
152 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51216659 |
153 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50272513 |
154 | Glioma_Homo sapiens_hsa05214 | 0.49736662 |
155 | Insulin secretion_Homo sapiens_hsa04911 | 0.49469755 |
156 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49308138 |
157 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49254452 |
158 | Hepatitis C_Homo sapiens_hsa05160 | 0.48159897 |
159 | Shigellosis_Homo sapiens_hsa05131 | 0.48085935 |
160 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44748403 |
161 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44078058 |
162 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41992063 |
163 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41282607 |
164 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39695186 |
165 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39543550 |
166 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38338884 |
167 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38226185 |